Emcure Shareholders Approve C S Muralidharan Director Appointment

Emcure Pharmaceuticals shareholders approved the appointment of Mr. C S Muralidharan as Independent Director via postal ballot e-voting.
The special resolution passed with 99.9999% votes in favor, effective from April 24, 2026.
Voting occurred from March 26 to April 24, 2026, with 141,769,539 votes cast representing 74.7771% of outstanding shares.
Scrutinizer Ashwini Inamdar of Mehta & Mehta certified the results on April 27, 2026.